SCHEMBL30422011

SCHEMBL30422011

N#Cc1ccncc1Sc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.71
KMT2A Q03164 2/20 0.71
PTGS1 P23219 2/20 0.50
PTGS2 P35354 2/20 0.50
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 3/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
SLC22A12 Q96S37 6/20 0.48
MAOA P21397 2/20 0.46
MAOB P27338 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
NCOA3 Q9Y6Q9 1/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
CYP3A4 P08684 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTT P42858 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30422446 0.89 KMT2A (0.76) MEN1KMT2APTGS1PTGS2ALDH1A1
SCHEMBL30421904 0.83 MEN1 (0.58) MEN1KMT2APTGS1PTGS2ALDH1A1
SCHEMBL30422573 0.82 KMT2A (0.69) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL30422065 0.82 MEN1 (0.57) MEN1KMT2APTGS1PTGS2ALDH1A1
SCHEMBL30422113 0.82 KMT2A (0.57) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL30422947 0.82 MEN1 (0.57) MEN1KMT2APTGS1PTGS2ALDH1A1
SCHEMBL30422506 0.82 MEN1 (0.57) MEN1KMT2APTGS1PTGS2ALDH1A1
SCHEMBL30422238 0.79 KMT2A (0.58) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL30422083 0.79 MEN1 (0.67) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL4011637 0.77 KDM4E (0.62) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250042886-A1 BIS(HETERO)ARYL THIOETHER OXADIAZINES AS FUNGICIDAL COMPOUNDS BAYER S.A.S. (FR) 2025-02-06 US disclosed
EP-4441049-A1 BIS(HETERO)ARYL THIOETHER OXADIAZINES AS FUNGICIDAL COMPOUNDS Bayer Aktiengesellschaft (DE) 2024-10-09 EP disclosed
WO-2023099445-A1 BIS(HETERO)ARYL THIOETHER OXADIAZINES AS FUNGICIDAL COMPOUNDS BAYER AKTIENGESELLSCHAFT (DE) 2023-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042886-A1 BIS(HETERO)ARYL THIOETHER OXADIAZINES AS FUNGICIDAL COMPOUNDS CYP4Z1, STS, HPD MEN1 4596/4885KMT2A 2899/4885PTGS1 3406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.